Hyperfine (HYPR) Cash from Financing Activities (2021 - 2026)

Hyperfine (HYPR) posted Cash from Financing Activities of $14.5 million for Q1 2026, down 24.87% on a QoQ basis from $19.3 million in Q4 2025, and up 159.51% year-over-year from $5.6 million in Q1 2025.

Hyperfine (HYPR) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Hyperfine's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $14.5 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 159.51% year-over-year to $14.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.4 million (up 456.16% YoY) and the FY2025 annual result came in at $27.5 million, up 2598.92% from the prior year.
  • Cash from Financing Activities was $14.5 million for Q1 2026 at Hyperfine, down from $19.3 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $19.3 million in Q4 2025 and bottomed at $5000.0 in Q4 2022.
  • A 5-year average of $3.1 million and a median of $58500.0 in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 100.0% — and 2025, when it jumped 35607.41%.
  • Hyperfine's Cash from Financing Activities stood at $5000.0 in 2022, then jumped by 460.0% to $28000.0 in 2023, then jumped by 92.86% to $54000.0 in 2024, then soared by 35607.41% to $19.3 million in 2025, then fell by 24.87% to $14.5 million in 2026.
  • Business Quant data shows HYPR's Cash from Financing Activities at $14.5 million in Q1 2026, $19.3 million in Q4 2025, and $2.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Hyperfine 92.81 Mn 51.53 Mn 1.98 Mn 14.49 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.49 Mn
Mar 31, 2026 14.49 Mn
Dec 31, 2025 19.28 Mn
Dec 31, 2025 19.28 Mn
Sep 30, 2025 2.16 Mn
Sep 30, 2025 2.16 Mn
Jun 30, 2025 474,000.00
Jun 30, 2025 474,000.00
Mar 31, 2025 5.58 Mn
Mar 31, 2025 5.58 Mn
Dec 31, 2024 54,000.00
Dec 31, 2024 54,000.00
Sep 30, 2024 851,000.00
Sep 30, 2024 851,000.00
Jun 30, 2024 59,000.00
Jun 30, 2024 59,000.00
Mar 31, 2024 55,000.00
Mar 31, 2024 55,000.00
Dec 31, 2023 28,000.00
Dec 31, 2023 28,000.00